The strange case of Canada’s Ebola vaccine became even stranger Monday.

That’s when the pharmaceutical multinational Merck announced it will pay $50 million for commercial rights to manufacture and develop the vaccine, invented at the federal government’s National Microbiological Laboratory in Winnipeg.

That a drug giant would shell out $50 million is not in itself peculiar. At a time when the rich world is close to panicking over Ebola, there are only two experimental vaccines aimed at the virus. Canada’s VSV-EBOV is one of them.

Europe and America have belatedly come to realize that Ebola is not just an African disease.

Read more


NEWSLETTER SIGN UP

Get the latest breaking news & specials from Alex Jones and the Infowars Crew.

Related Articles


Comments